Management of salivary gland malignancy: ASCO guideline

JL Geiger, N Ismaila, B Beadle, JJ Caudell… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

Premalignant and malignant oral mucosal lesions: Clinical and pathological findings

MBC Maymone, RO Greer, J Kesecker… - Journal of the American …, 2019 - Elsevier
The second article in this continuing medical education series discusses the clinical and
histopathologic features of common premalignant and malignant lesions of the oral cavity. It …

[HTML][HTML] Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis

G Cantù - Acta Otorhinolaryngologica Italica, 2021 - ncbi.nlm.nih.gov
The purpose of this review is to analyse the very large number of studies (sometimes
contradictory) on adenoid cystic carcinoma (ACC). This second part provides a critical …

Contemporary management of benign and malignant parotid tumors

J Thielker, M Grosheva, S Ihrler, A Wittig… - Frontiers in …, 2018 - frontiersin.org
To report the standard of care, interesting new findings and controversies about the
treatment of parotid tumors. Relevant and actual studies were searched in PubMed and …

Radiation therapy for adenoid cystic carcinoma of the head and neck

CA Rodriguez-Russo, JC Junn, SS Yom, RL Bakst - Cancers, 2021 - mdpi.com
Simple Summary Adenoid cystic carcinoma is a rare histology arising in the head and neck
region that has a high propensity for perineural invasion. While surgical resection is the …

Impact of adjuvant radiotherapy for malignant salivary gland tumors

J Safdieh, B Givi, V Osborn… - … –Head and Neck …, 2017 - journals.sagepub.com
Objective Using the National Cancer Database (NCDB), we investigated the characteristics,
outcomes, and benefits of adjuvant therapy for patients diagnosed with malignant salivary …

Choice of adjuvant radiotherapy facility in major salivary gland cancer

AM Patel, A Haleem, R Maxwell, JN Lukens… - The …, 2024 - Wiley Online Library
Objective Undergoing surgery and adjuvant radiotherapy (aRT) at the same facility has been
associated with higher overall survival (OS) in head and neck squamous cell carcinoma. Our …

Trophoblast cell surface antigen 2 (Trop-2) protein is highly expressed in salivary gland carcinomas and represents a potential therapeutic target

P Wolber, L Nachtsheim, F Hoffmann… - Head and neck …, 2021 - Springer
Abstract Treatment options for unresectable, recurrent or metastatic salivary gland
carcinomas (SGC) are scarce. Trophoblast cell surface antigen 2 (Trop-2) is a …

Role of postoperative radiotherapy in nonmetastatic head and neck adenoid cystic carcinoma

Y Chen, ZQ Zheng, FP Chen, JY Yan… - Journal of the National …, 2020 - jnccn.org
Background: Head and neck adenoid cystic carcinoma (ACC) is a rare malignant tumor that
is prone to local recurrence. The NCCN Guidelines for Head and Neck Cancers recommend …

A molecular guide to systemic therapy in salivary gland carcinoma

AN Weaver, S Lakritz, D Mandair, MB Ulanja… - Head & …, 2023 - Wiley Online Library
Salivary gland carcinomas (SGC) are a rare and variable group of head and neck cancers
with historically poor response to cytotoxic chemotherapy and immunotherapy in the …